832_epat care: PATIENT CASE dr. aguilaniu dr

Slides:



Advertisements
Similar presentations
Pulmonary Function Testing
Advertisements

These are actual cases to: –Stimulate your reading –Test your knowledge of the material Look for the sound icon (usually in the upper right hand corner.
Diagnostic tools – imaging and lung function (humans)
Idiopathic pulmonary fibrosis (IPF) – The need for early recognition and referral PRC-2128.
Interstitial lung disease in systemic sclerosis
Coinvolgimento polmonare nella sclerosi sistemica Marco Matucci Cerinic Departments of Rheumatology AVC BioMedicine & Division of Rheumatology AOUC Medicine,
Case of combined pulmonary fibrosis with emphysema(CPFE) and its importance to recognize Abstract ID
Clinical History Locke : 55 yo male past medical history of hypothyroidism presents with increasing dyspnea. Patient was treated with several.
INTERSTITIAL LUNG DISEASE
IDIOPATHIC PULMONARY FIBROSIS
THE DIAGNOSIS OF IPF Steven A. Sahn, MD
IDIOPATHIC PULMONARY FIBROSIS
Respiratory function tests
Asbestos Exposure Frans Naude.
Living with Pulmonary Fibrosis Gerard Cox FIRH – SJHH McMaster University Sept 2013.
NYU Medical Grand Rounds Clinical Vignette Lucy Doyle MD, PGY-2 March 24, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Adult Medical-Surgical Nursing Respiratory Module: Diagnostic Tests.
Esam H. Alhamad, M.D Assistant Professor of Medicine Consultant Pulmonary & Critical Care Medicine.
Idiopathic Pulmonary Fibrosis: Diagnosis and Understanding
1 Pulmonary Function Tests J.B. Handler, M.D. Physician Assistant Program University of New England.
Pulmonary Function Tests (PFTs)
History : 52-year-old male presented with a left testicular mass. An initial chest radiograph was performed, followed by a CT. Question : What are the.
Copyright © 2006 by Mosby, Inc. Slide 1 PART IX Diffuse Alveolar Disease.
PFF Teal = MAIN COLORS PFF Green = Light Green = Red = HIGHLIGHT COLORS Light Grey = Dark Grey =
History : 67 year old male, non smoker, presents with over a month history of fevers, chills, anorexia and malaise despite antibiotic treatment for presumptive.
Interstitial Lung Diseases Pulmonary Medicine Department Ain Shams University
Should it be viewed as a single entity? Hypersensitivity pneumonitis Should it be viewed as a single entity? Venerino Poletti versus Athol Wells.
Ganesh Raghu, Harold R. Collard, Jim J. Egan, Fernando J. Martinez, Juergen Behr, Kevin K. Brown et al on behalf of the ATS/ERS/JRS/ALAT Committee on Idiopathic.
Clinical Case 11 th February th Course of Diffuse Parenchymal Lung Diseases.
History : 38-year-old male with progredient dyspnea, productive cough, frequent airway infections and restrictive ventilatory defect. BAL and Biopsy were.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Demystifying Idiopathic Interstitial Pneumonia Arch.
Emerging Approaches to Treatment of IPF Gregory P. Cosgrove, MD Associate Professor, Pulmonary Division Assistant Director, Interstitial Lung Disease Program.
IPF Diagnostic Methods and Differential Diagnosis
Through The Looking Glass
Diseases of the respiratory system lecture 5
Department of Respiratory Medicine
PFT of the Day!.
Lung function in health and disease
Other Important Topics
Recent Advances in Idiopathic Pulmonary Fibrosis
Masaaki Sato, MD, PhD, David M. Hwang, MD, PhD, Thomas K
Subjects characteristics
Figure 1. Suggested algorithm for locoregional lymph node staging in patients with non-metastatic NSCLC. CT, computed tomography; EBUS, endoscopic bronchial.
Case of combined pulmonary fibrosis and emphysema (CPFE) PROF. dr
UIP or not UIP Pattern: That is not the Only Question
Patient with IPF and no honeycombing on HRCT
To treat or not to treat? IPF and preserved lung function
Idiopathic Pulmonary Fibrosis: Current Concepts
831_ePAT CARE: Patient case Dr. Molina Dr
The Role of Imaging in Diagnosing IPF Hands-On Case Studies
Patient with IPF and concomitant emphysema
Combined pulmonary fibrosis and emphysema (CPFE): an increasingly diagnosed condition Authors: Giovanna Elisiana Carpagnano (Foggia) Ennio Vincenzo.
CASE HISTORY Dr. Zahoor.
Respiratory MCNs - Interstitial lung diseases
Name: Age: Sex: Presenting History Symptom progression Current status:
Trials and the Tyranny of Arbitrary Cut-offs in Idiopathic Pulmonary Fibrosis David thickett 11 July 2014.
Patient with FVC>90% predicted
Changes in high-resolution computed tomography (HRCT) pattern over time. a) Idiopathic pulmonary fibrosis (IPF), increased specificity over time. Changes.
Longitudinal imaging after initial diagnosis
Interstitial lung disease
High-resolution computed tomography (HRCT) features of interstitial lung abnormalities. a) HRCT of a 56-year-old patient whose mother died of idiopathic.
Michael E. Halkos, MD, Anthony A. Gal, MD, Faraz Kerendi, MD, Daniel L
Rheumatoid Arthritis-Associated Interstitial Lung Disease
PPFE: frequency and diagnosis
3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ
Axial computed tomography (CT) images a) at baseline and b) at a 12-month follow-up scan, in a patient with idiopathic pulmonary fibrosis (IPF). b) Note.
How is pulmonary fibrosis diagnosed and monitored?
Nonspecific interstitial pneumonia: high-resolution computed tomography images from a 46-year-old male patient who underwent lung transplantation. a) The.
The Histopathology of IPF
Evaluation of acute symptoms
Presentation transcript:

832_epat care: PATIENT CASE dr. aguilaniu dr 832_epat care: PATIENT CASE dr. aguilaniu dr. bernard Aguilaniu (Grenoble, France) dr. Benoit Wallaert (lille, France) Case#1 Received 12/06/2014

Case Overview Short description: An asymptomatic smoker was diagnosed with mild interstitial lung disease (either early interstitial pulmonary fibrosis (IPF) or non- specific interstitial pneumonia (NSIP)). Initially, the patient refused lung biopsy, but he eventually agreed because his symptoms worsened over the years. Seven years after his first visit, he received a lung transplant. Here we discuss the natural history of this case of IPF, which was detected by chance before the presence of significant symptoms, and the clinical management problems caused by this unusual situation.

Patient Anamnesis - 1999 The patient requested a pulmonary check-up because his brother had died after a surgical lung biopsy conducted for the diagnosis of interstitial lung disease. Initial visit (1/1999) 58-year-old male Smoker No occupational or environmental hazards Brother died after surgical lung biopsy (conducted for diagnosis of interstitial lung disease) Clinical data No symptoms No drugs SpO2: 97% (normal) Heart rate: 72 bpm (normal) Physical examination No cyanosis No clubbing No clinical sign of systemic disease The first pulmonary auscultation was almost normal, but minimal crackles were heard in the posterior regions of the thorax.

Imaging – 1999 – chest radiograph Chest radiography (1999) was considered normal

Lung function - 1999 Conclusion Forced expiration measurement: Forced vital capacity is within the normal range No bronchial obstruction observed Pulmonary diffusion measurement: Pulmonary diffusion measurements show a low DLCO Cardiopulmonary exercise testing (CPET): CPET shows a mild pulmonary gas exchange disturbance, whilst the maximal work capacity is modest Conclusion Because of “minimal crackles” at auscultation and the low DLCO value, a CT scan was performed.

Forced expiration measurement (1999) Lung function - 1999 Forced expiration measurement (1999) Value Absolute % of predicted FVC (L) 4.0 97 FEV1 (L) 3.3 100 FEV1/ FVC (%) 82

Lung volume measurement (1999) Lung function - 1999 Lung volume measurement (1999) Value Absolute % of predicted TLC (L) 5.6 83 FRC (L) 3.1 90 IC (L) 2.6 78 RV (L) 1.4 61 RV/TLC (%) 25 74 SVC (L) 4.3 96

Pulmonary diffusion measurement (1999) Lung function - 1999 Pulmonary diffusion measurement (1999) Value Absolute % of predicted DLCO (mlCO/min/mmHg) 20.2 72 KCO (DLCO/VA) 3.52 84

Cardiopulmonary exercise testing (CPET) (1999) Lung function - 1999 Cardiopulmonary exercise testing (CPET) (1999) Value Absolute % of predicted VO2Max (mlO2/(kg/min) 23.7 80 WRMAX (Watts) 104 PaO2rest (mmHg) 94 ∆ = -12 PaO2max (mmHg) 82 P(A-a)O2max (mmHg) 31 VD/VTmax (%) 26

Imaging – 1999 - CT CT scan in 1999 shows: Intralobular reticulation Subpleural localisation Predominance in lower lobes

Imaging – 1999 - CT

Imaging – 1999 - CT

Imaging – 1999 - CT

Question 1 What pattern does the CT scan show? UIP Inconsistent with UIP Possible UIP*

Answer 1 Author’s solution: Correct answer: possible UIP The CT scan shows: Intralobular reticulation Subpleural localisation Predominance in lower lobes Traction bronchiectasis and honeycombing are absent. This means that the patient exhibits a possible radiological UIP pattern. Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183(6):788-824.

Laboratory results in 2000: LDH Normal Immunology No positive auto-antibodies ACE Serum precipitins Haematology Biochemistry Normal inflammatory markers; Creatine kinase normal Rajouter CPK

Bronchoscopy Bronchoscopy performed in 2000 Macroscopic assessment: Normal Bronchoalveolar lavage (BAL) differential cell count: Abnormal, due to polymorphonuclear (neutrophilic and eosinophilic) pattern BAL differential cell count: patient Alveolar macrophages 78 % Neutrophils 12 % Lymphocytes 6 % Eosinophils 4 %

Biopsy Lung biopsy was proposed in 2000, but this was rejected by the patient (because his brother had died after a surgical lung biopsy).

Diagnosis - 2000 Radiologically, the patient exhibits a possible UIP pattern (no honeycombing) Other possible diagnoses are negative This leads to the conclusion that this asymptomatic smoker has an idiopathic interstitial pneumonia with the following possible diagnoses: Early IPF Non-specific interstitial pneumonia

Expert panel Pop up: Diagnosis What are the next steps that need to be taken? The treating physician should inform the patient that his lung function could deteriorate in the future and that he therefore needs to be followed up every six months.

Patient anamnesis - 2001 2001 (surveillance every 6 months) Patient is still asymptomatic Slight worsening of the reticular pattern on CT Stable pulmonary function at rest and on exercise Patient still refuses lung biopsy

Imaging – 2001 - CT A second CT scan in 2001 shows slight worsening of the reticular pattern. 2001 1999

Rest and exercise pulmonary function remain stable from 2000-2001. Lung function- 2001 Rest and exercise pulmonary function remain stable from 2000-2001. 2000 2001 FVC (L) 4.0 FEV1 (L) 3.3 TLC (ml/min/mmHg) 5.6 5.9 DLCO (ml/min/mmHg) 20.2 18.8 PaO2rest (mmHg) 94 VO2 Max (mlO2 /(kg*min) 23.7 23 WR MAX (Watts) 105 98 PaO2max (mmHg) 82 76 P(A-a)O2max (mmHg) 31 36 VD/VTmax (%) 26

2002 (surveillance every 6 months) Patient anamnesis - 2002 2002 (surveillance every 6 months) The patient exhibits an onset of symptoms late in 2002. Mainly dry cough No dyspnoea

Imaging – 2002 - CT CT scan in 2002 shows a mild increase of intralobular reticulation compared to 1999, without honeycombing or traction bronchiectasis. 1999 2002 si

Imaging – 2002 - CT 1999 2002

Rest and exercise pulmonary function (2002) Lung function - 2002 Decreased DLCO Increased P(A-a)O2max and VD/Vtmax Conclusion: Deterioration of rest (DLCO) and exercise pulmonary gas exchange without significant change in lung volume Rest and exercise pulmonary function (2002) 2000 2001 2002 FVC (L) 4.0 3.9 FEV1 (L) 3.3 TLC (ml/min/mmHg) 5.6 5.9 5.8 DLCO (ml/min/mmHg) 20.2 18.8 16.3 PaO2rest (mmHg) 94 100 VO2 Max (mlO2 /(kg*min) 23.7 23 WR MAX (Watts) 105 98 PaO2max (mmHg) 82 76 74 P(A-a)O2max (mmHg) 31 36 48 VD/VTmax (%) 26

Question 2 Question: What diagnostic procedure should be suggested to the patient? Perform chest radiography in order to compare it with the CT results. Repeat the BAL measurements conducted in 2000. Perform a lung biopsy in order to determine histological UIP pattern.* Repeat the CT scan to exclude scanning artefacts.

Question 2 Author’s solution: Correct answer: Perform a lung biopsy in order to determine histological UIP pattern. Lung function tests show a functional aggravation, in particular in pulmonary gas exchange and the CT scan of this patient shows a possible UIP pattern. In order to confirm or reject the diagnosis of IPF, a surgical lung biopsy is needed. Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183(6):788-824.

Biopsy - 2003 The patient consented to Video-Assisted Thoracoscopic Surgery (VATS) in 2003. Samples were taken from the superior and inferior lobe of the left lung.

Pathology The biopsy shows: Fibroblastic foci Honeycombing Sub-pleural predominance Temporal heterogeneity Histological conclusion: The lung biopsy pattern is consistent with a UIP pattern. Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183(6):788-824.

Pathology Honeycombing Sub-pleural predominance Fibroblastic foci

Diagnosis - 2003 Based on the radiological (possible UIP) and histological (UIP) patterns detected, the final diagnosis of this patient is idiopathic pulmonary fibrosis (IPF). Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183(6):788-824.

Patient anamnesis – 2003, 2004, 2005 Overview of the treatment the patient received 2003 Combination of azathioprine, prednisone and N-acylcysteine 2004 Cyclophosphamide bolus for an episode of subacute exacerbation (administered on 15 days over a time period of three months). Morawiec E, Tillie-Leblond I, Pansini V, Salleron J, Remy-Jardin M, Wallaert B. Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses. Eur Respir J. 2001;38(6):1487-9. 2005 Oxygen therapy during walking Pulmonary rehabilitation Treatment with interferonɣ-1b

Rest and exercise pulmonary function (2003, 2004, 2005) Lung function – 2003, 2004, 2005 Despite treatment, the patient exhibited a decline of over 20% in FVC in 2004 after the exacerbation. Pulmonary function parameters remained relatively stable between 2004 and 2005 whilst on treatment with interferonɣ-1b. Rest and exercise pulmonary function (2003, 2004, 2005) 11/2003 05/2004 05/2005 FVC (L) 3.1 2.8 2.7 FEV1 (L) 2.4 DLCO (ml/min/mmHg) 8.2 7.7 7.5 WR MAX (Watts) 98 90 60 VO2 Max (mlO2 /(kg*min) 24 16.7 13.4 PaO2max (mmHg) 55 46 52 P(A-a)O2max (mmHg) 62 70 67 VD/VTmax (%) 43 41

Imaging - 2005 The CT scan in 2005 shows aggravation cysts.

Imaging - 2005 The CT scan in 2005 shows traction bronchiectasis and honeycombing.

Lung function testing (2006) During the course of six months, the patient exhibits a further decline in FVC of 10%. Lung function testing (2006) 03/2006 10/2006 FVC (L) 2.4 2.1 FEV1 (L) 2.2 1.9 TLC ( 4.3 DLCO (ml/min/mmHg) 5.8 2.5 PaO2 rest (mmHg) 82 55

Patient anamnesis - 2006 This deterioration lead to an alteration of treatment in 10/2006: Stop treatment with interferong-1b Start treatment with octreotide Crestani B, et al. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Eur Resp J. 2012;39:772-775.

Operating Theatre - 2007 The patient underwent a lung transplant in 2007 and is currently well with a good quality of life despite recurrent infectious complications.

Operating Theatre - 2007 1999 2007

Learnings from the case The most important take home messages of the case are: Lung crackles and even slight decrease in DLCO over several successive measurements can be early signs of IPF and should not be ignored. Reduction of pulmonary gas exchange during exercise can precede the decrease in lung volumes measured at rest. IPF may be present without visible honeycombing on CT. In this case, IPF can be confirmed by lung biopsy. Being asymptomatic does not exclude the diagnosis of IPF.